array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(24) "Idexx Laboratories, Inc."
["slug"]=>
string(31) "52dfe-us-idexx-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62"
["description"]=>
string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities."
["address_street"]=>
string(10) "1 Idexx Dr"
["address_place"]=>
string(9) "Westbrook"
["address_region"]=>
string(5) "Maine"
["founding_date"]=>
string(10) "1983-02-28"
["website_domain"]=>
string(9) "idexx.com"
["website_url"]=>
string(21) "https://www.idexx.com"
["industry_codes"]=>
array(4) {
[0]=>
string(43) "General Livestock, Except Dairy and Poultry"
[1]=>
string(33) "Veterinary Services for Livestock"
[2]=>
string(27) "Pharmaceutical Preparations"
[3]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
}
["employee_count"]=>
int(710)
["article_count"]=>
int(640)
}
["articles"]=>
array(7) {
[0]=>
array(7) {
["title_en"]=>
string(168) "Immunopathological investigation and genetic evolution of Avian leukosis virus Subgroup-J associated with myelocytomatosis in broiler flocks in Egypt - Virology Journal"
["snippet_en"]=>
string(296) "Background Avian leukosis virus Subgroup-J (ALV-J) is a rapidly oncogenic evolving retrovirus infecting a variety of avian species; causing severe economic losses to the local poultry industry. Methods To investigate ALV-J, a total of 117 blood samples and 57 tissue specimens of different organs"
["url"]=>
string(71) "https://virologyj.biomedcentral.com/articles/10.1186/s12985-024-02329-7"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/22af36e8-b4eb-4e38-ad9a-9d7eea02aef8"
["source"]=>
string(17) "biomedcentral.com"
["publication_date"]=>
string(10) "2024-04-10"
["categories"]=>
array(1) {
[0]=>
string(25) "Business Model Resilience"
}
}
[1]=>
array(7) {
["title_en"]=>
string(67) "IDEXX Labs Lifts FY23 Earnings View, Cuts Revenue Forecast - Update"
["snippet_en"]=>
string(226) "IDEXX Laboratories Inc (IDXX), while reporting higher third-quarter results, on Wednesday raised its fiscal 2023 earnings view, but trimmed revenue forecast.For the full year, the company now expects earnings in a range of $9."
["url"]=>
string(101) "https://www.rttnews.com/3401408/idexx-labs-lifts-fy23-earnings-view-cuts-revenue-forecast-update.aspx"
["image_url"]=>
NULL
["source"]=>
string(11) "rttnews.com"
["publication_date"]=>
string(10) "2023-11-01"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(25) "Business Model Resilience"
[3]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(32) "Idexx Adds a Third PIMS Platform"
["snippet_en"]=>
string(140) "Idexx Laboratories Inc. has acquired ezyVet, a New Zealand-based practice information management system, and a satellite company, Vet Radar."
["url"]=>
string(59) "https://todaysveterinarybusiness.com/idexx-acquires-ezyvet/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/18f7da5e-8728-4592-b352-a2907f80575c"
["source"]=>
string(28) "todaysveterinarybusiness.com"
["publication_date"]=>
string(10) "2021-06-21"
["categories"]=>
array(3) {
[0]=>
string(14) "Product Launch"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(11) "Acquisition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(55) "IDEXX U.S. Companion Animal Group Now Offers Online ..."
["snippet_en"]=>
string(247) "02-12-2014· IDEXX U.S. Companion Animal Group Now Offers Online Ordering via Industry-Leading E-commerce Platform New platform offers unique ordering capabilities, while the completely redesigned U.S. Small Animal Health customer website provides"
["url"]=>
string(118) "https://www.idexx.com/en/about-idexx/news/newsroom-archive/idexx-us-companion-animal-group-now-offers-online-ordering/"
["image_url"]=>
NULL
["source"]=>
string(9) "idexx.com"
["publication_date"]=>
string(10) "2014-12-02"
["categories"]=>
array(1) {
[0]=>
string(25) "Business Model Resilience"
}
}
[4]=>
array(7) {
["title_en"]=>
string(66) "IDEXX launches $35M facility expansion as company continues growth"
["snippet_en"]=>
string(160) "WESTBROOK, Maine — IDEXX Laboratories CEO Jonathan Ayers said Tuesday’s announced $35 million expansion of the company’s Westbrook headquarters will allow"
["url"]=>
string(110) "https://bangordailynews.com/2012/04/03/news/idexx-launches-35m-facility-expansion-as-company-continues-growth/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6946ef75-5cc7-40a5-b56f-4148bc5d76d5"
["source"]=>
string(19) "bangordailynews.com"
["publication_date"]=>
string(10) "2012-04-03"
["categories"]=>
array(2) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(18) "Expansion & Growth"
}
}
[5]=>
array(7) {
["title_en"]=>
string(54) "IDEXX only Maine company to make the Fortune 1000 list"
["snippet_en"]=>
string(243) "IDEXX Laboratories Inc. of Westbrook made it into the Fortune 1000 list of the largest publicly traded companies for the first time, coming in at 961 in the annual ranking of companies by annual revenue. IDEXX's 2017 revenue was $1.97 billion."
["url"]=>
string(87) "https://www.mainebiz.biz/article/idexx-only-maine-company-to-make-the-fortune-1000-list"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4055fdad-b600-47db-9974-11d2b3588199"
["source"]=>
string(12) "mainebiz.biz"
["publication_date"]=>
NULL
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[6]=>
array(7) {
["title_en"]=>
string(58) "Validea Detailed Fundamental Analysis - IDXX - ProInvestor"
["snippet_en"]=>
string(279) "Below is Validea's guru fundamental report for IDEXX LABORATORIES, INC. (IDXX). Of the 22 guru strategies we follow, IDXX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks t"
["url"]=>
string(90) "https://www.proinvestor.com/investornyt/1092974/validea-detailed-fundamental-analysis-idxx"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e039f806-0193-4bbe-b761-6d28e3de366d"
["source"]=>
string(15) "proinvestor.com"
["publication_date"]=>
NULL
["categories"]=>
array(2) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(15) "Market Movement"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(117)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(65)
}
[2]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(43)
}
[3]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(43)
}
[4]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(40)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(22)
}
[7]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(22)
}
[8]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(21)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(18)
}
[11]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[12]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[14]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(9)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[26]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(5)
}
}
}
52dfe-us-idexx-laboratories-inc
Idexx Laboratories, Inc.
Location
Maine
Founded
1983-02-28
Website
https://www.idexx.com
Articles
640 Articles
Category
General Livestock, Except Dairy and Poultry
Veterinary Services for Livestock
Pharmaceutical Preparations
In Vitro and In Vivo Diagnostic Substances
Description
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
Background Avian leukosis virus Subgroup-J (ALV-J) is a rapidly oncogenic evolving retrovirus infecting a variety of avian species; causing severe economic losses to the local poultry industry. Methods To investigate ALV-J, a total of 117 blood samples and 57 tissue specimens of different organs
IDEXX Laboratories Inc (IDXX), while reporting higher third-quarter results, on Wednesday raised its fiscal 2023 earnings view, but trimmed revenue forecast.For the full year, the company now expects earnings in a range of $9.
02-12-2014· IDEXX U.S. Companion Animal Group Now Offers Online Ordering via Industry-Leading E-commerce Platform New platform offers unique ordering capabilities, while the completely redesigned U.S. Small Animal Health customer website provides
WESTBROOK, Maine — IDEXX Laboratories CEO Jonathan Ayers said Tuesday’s announced $35 million expansion of the company’s Westbrook headquarters will allow
IDEXX Laboratories Inc. of Westbrook made it into the Fortune 1000 list of the largest publicly traded companies for the first time, coming in at 961 in the annual ranking of companies by annual revenue. IDEXX's 2017 revenue was $1.97 billion.
Below is Validea's guru fundamental report for IDEXX LABORATORIES, INC. (IDXX). Of the 22 guru strategies we follow, IDXX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks t
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
